Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor

the VM202 study group

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds